Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation. - Wikidata - awgldk - TriplyDB

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

http://www.wikidata.org/entity/Q37409854

about

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

http://www.wikidata.org/entity/Q37409854

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

@en

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

@nl

type

label

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

@en

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

@nl

prefLabel

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

@en

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation.

@nl

P1433

Q37409854-06E0B410-5F07-4426-9457-7EA48A3A01E4

P1476

Q37409854-AAEA477A-8C02-4F18-9177-B944574992D2

P2093

Q37409854-242AC586-1437-43F7-8BD4-EC8143DDDC3B

Q37409854-5D0A7F52-0976-489A-A4C7-C23CDF6652FD

Q37409854-F51E23C7-A222-45EF-8596-AB5B495857E0

Q37409854-F9F24453-FEAE-44CC-AE81-2338478A01E3

Q37409854-FBC2A4D9-759A-4506-885F-79C57F819EE5

P2860

Q37409854-0F96249E-3DD6-4DA8-A6DC-65E37A8C5311

Q37409854-1D5BF98C-797E-4576-B7C4-5D08034EF1EE

Q37409854-23926C47-0A82-415F-A243-897FF15AEBF2

Q37409854-2E357FD9-52E3-4749-8699-92909A2D90BA

Q37409854-32D224BB-4A54-491C-BA9A-FE1D4D9110CA

Q37409854-338F0768-0864-4AAC-B19F-D3C098F70EB0

Q37409854-4F8C7638-F982-4FEC-9FB0-82BEA01A8FCA

Q37409854-4FA52D8A-80D4-4E66-B48F-7726C9977439

Q37409854-53B309F7-72AF-4EA9-A37E-C245A567E9C4

Q37409854-5F2D046F-A665-444D-9FA8-1D1FC4BCA501

P2888

Q37409854-70A0DED1-FA40-4652-8044-F04712426EBD

P304

Q37409854-576A12CD-E0E4-4CA1-A1E4-CD077F93F2AD

P31

Q37409854-57972424-36EB-4E84-A6E1-408A4A14F3B4

P356

Q37409854-AF0D78D3-713F-436D-AFBB-A2EEBE51ED32

P433

Q37409854-95DF60C7-CBE1-4D73-8ECD-31146AA9A2B7

P478

Q37409854-8014EA54-7C5C-486B-B045-65B47F007F78

P50

Q37409854-618B2B89-2EE9-4EDD-9DD6-24CF1A03FF75

P577

Q37409854-2CAF7E52-6644-4772-9E60-1B3F8E4D22A0

P698

Q37409854-DAD9171B-3E3A-4018-A830-4D06FA99C783

P932

Q37409854-1E1DFA8E-7DF0-4894-85F2-256034AAC259

P356

P1433

The Journal of Antibiotics

P1476

Kinetic characterization of GES-22 β-lactamase harboring the M169L clinical mutation

@en

P2093

Aysegul Copur Cicek

http://www.w3.org/2001/XMLSchema#string

Aysegul Saral

http://www.w3.org/2001/XMLSchema#string

Azer Ozad Duzgun

http://www.w3.org/2001/XMLSchema#string

Cynthia M June

http://www.w3.org/2001/XMLSchema#string

David A Leonard

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases: a clinical update

Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin

Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases

Kinetic and Crystallographic Studies of Extended-Spectrum GES-11, GES-12, and GES-14 -Lactamases

GES-18, a New Carbapenem-Hydrolyzing GES-Type -Lactamase from Pseudomonas aeruginosa That Contains Ile80 and Ser170 Residues

Structural Basis for Progression toward the Carbapenemase Activity in the GES Family of β-Lactamases

Structures of the Class D Carbapenemases OXA-23 and OXA-146: Mechanistic Basis of Activity against Carbapenems, Extended-Spectrum Cephalosporins, and Aztreonam

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.

GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.

P2888

P304

858-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JA.2016.48

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27168312

http://www.w3.org/2001/XMLSchema#string

P932

5106332

http://www.w3.org/2001/XMLSchema#string